MediPharm stock is trading down slightly despite MediPharm Labs (TSX:LABS) (OTCQX:MEDIF) increasing its exports of medical cannabis concentrate to Australia.
MediPharm Stock Down on Australia ExpansionMediPharm Labs Corp, a Canadian market leader in cannabis extraction and cannabinoid isolation, announced this morning that it had successfully completed its second cannabis concentrate export to Australia, at a volume 137% greater than the previous shipment in June. Health Canada also gave the company a second set of permits so that MediPharm could ship more medical cannabis concentrates to Australia. MediPharm stock is down 2.6% to $3.35 during Wednesday ...
Read The Full Article On PotStockNews.com
Get the latest marijuana stock news, cannabis on stock news on PotStockNews
All content provided by Pot Stock News is subject to our Terms Of Use and Disclaimer.